Digital PCR-dPCR Market Trends and Overview

The market size of Digital PCR (dPCR) was valued at US$ 419.25 million in 2022 and is projected to reach US$ 2,196.40 million by 2030, exhibiting a robust compound annual growth rate (CAGR) of 23% during the forecast period from 2023 to 2030.

Digital PCR (dPCR) is a rapidly expanding market that is expected to witness substantial growth in the coming years. With a CAGR of 23%, the market is poised to reach a valuation of US$ 2,196.40 million by 2030, up from US$ 419.25 million in 2022.

The increasing adoption of dPCR technology across various industries, including healthcare, pharmaceuticals, and research, is a key driver behind this remarkable growth. Digital PCR offers several advantages over traditional PCR methods, such as improved sensitivity, precision, and absolute quantification of nucleic acids. These benefits have fueled the demand for dPCR, leading to its widespread adoption in applications like genetic testing, disease diagnosis, and drug development.

Furthermore, the rising prevalence of chronic diseases, such as cancer and infectious diseases, has created a pressing need for accurate and reliable diagnostic tools. Digital PCR, with its ability to detect and quantify rare genetic mutations and pathogens, has emerged as a valuable tool in precision medicine and personalized healthcare.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1038

Geographically, North America currently dominates the dPCR market, owing to the presence of well-established healthcare infrastructure, technological advancements, and a strong focus on research and development. However, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing investments in healthcare infrastructure, rising awareness about advanced diagnostic techniques, and a growing emphasis on precision medicine.

KEY MARKET SEGMENTATION:

By Technology

• Droplet Digital PCR
• Chip Based Digital PCR
• Beaming Digital PCR

By Product Type

• Digital PCR Systems
• Consumables And Reagents
• Software And Services

By Application

• Clinical Diagnostics
• Forensic And Others
• Research

By End-Use

• Pharmaceuticals And Biotechnology Industries
• Clinical Diagnostic Laboratories
• Universities And Other Organizations

KEY PLAYERS:

The Major Players are Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMérieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group, Quidel Corporation, and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com